Word count abstract: 156 Word count article: 1244 Abstract 1 Background: Hepatitis B viruses (HBV) harboring mutations in the a-determinant of the 2 Hepatitis B surface antigen (HBsAg) are associated with reduced reactivity of HBsAg assays. 3
Highlights
HBsAg point-of-care tests have slightly lower sensitivities than standard methods. We assessed test characteristics of point-of-care tests using HBsAg mutated viruses. The point-of-care tests accurately diagnosed mutated Hepatitis B viruses. HBsAg mutations do not affect the sensitivity of the evaluated tests.
*Highlights (for review)
Background 23 The mainstay of Hepatitis B virus (HBV) infection diagnosis is the detection of the HBV 24 surface antigen (HBsAg) [1] . In recent years an increasing number of HBsAg point-of-care 25 (POC) tests have become available. POC tests, which use the principle of 26 immunochromatography as well as enzyme immunoassays and chemiluminescence 27 immunoassays, are based on the detection of the antigenic determinant -. 28
The a-determinant is located between amino acid position 99 and 160 of the HBsAg [2] . 29
However, in a recent study from The Gambia, POC tests had a slightly lower sensitivity than 30 the standard serological methods [3] . In diagnostic-escape variants, mutations in the a-31 determinant of the HBsAg are thought to influence the performance of HBsAg assays [2] . 32
The diagnostic performance for mutant HBV has been shown to differ across commercial 33 1`139-329`750 IU/ml). Genotype D was the most prevalent (52.0%, 13/50) followed by A 80 (26.0%, 13/50), B (10.0%, 5/50), C (6.0%, 3/50), E (4.0%, 2/50) and F (2.0%, 1/50). 81
The sensitivity and specificity of the HBsAg POC tests were excellent ( Table 2) Discussion 93 This is the first study to assess the performance of HBsAg POC tests in diagnosing HBV 94 harboring HBsAg mutations from clinical samples. We showed that the sensitivity and 95 specificity of the assays were excellent. mutations. However, we did not have samples with low viral loads, as we only included those 105 which were successfully sequenced and therefore the sensitivities of the POC test may be 106 overestimated. We used plasma, which, according to the manufacturer`s information, leads 107 to a slightly higher sensitivity than whole blood with the Vikia® assay. However, this is not 108 true for the Alere Determine -and unknown for the Quick Profile assay. 109
In line with findings from Muhlbacher et al, we showed that a specific mutation did not always 110 have the same effect on the result of the assay [18] . In our study the sample with a single 111 D144A mutation was not detected by one of the tests, whereas for viruses harboring 112 additional mutations, the result was either borderline positive or clearly positive. This 113 phenomenon was not explained by lower quantities of HBsAg in the false-negative sample. 114
This was the first study to evaluate the sensitivity of HBsAg POC tests for diagnostic escape 115 mutants using clinical samples with a wide variety of mutations and HBV genotypes. We 116 recognize that in clinical settings, HBsAg POC tests are generally performed using whole 117 blood and not serum or plasma. However, in light of recently published evidence, we did not 118 expect the use of plasma to affect our results significantly [19] . 119
In conclusion we demonstrated that the three HBsAg POC tests accurately diagnosed 120 
